96 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

6652

Eusol BiotechLtd
NT$7.52-5.9%-24.6%NT$1.0bn/aPB2.7xn/an/a

6586

CHO Pharma
NT$50.80-4.3%-28.5%NT$10.9bn/aPS10047.8xn/an/a

6589

EirGenix
NT$89.800.9%-11.5%NT$27.5bNT$120.33PS23.4xE38.2%n/a

6986

HeXun Biosciences
NT$73.704.4%11.7%NT$3.4bn/aPE27.3xn/an/a

6709

Advagene Biopharma
NT$20.00-9.3%-20.9%NT$1.2bn/aPB10.9xn/an/a

4114

Synmosa Biopharma
NT$34.90-1.1%1.6%NT$14.6bNT$36.00PE20.4xS12.7%1.6%

4169

TCM Biotech International
NT$58.40-2.7%-0.2%NT$3.4bNT$113.00PE172.4xn/a0.5%

6838

Formosa Pharmaceuticals
NT$38.90-5.7%-23.1%NT$5.9bn/aPS42.7xn/an/a

6926

Shine-On BioMedicalLtd
NT$65.800.9%4.1%NT$3.3bn/aPS344.1xn/an/a

4162

PharmaEngine
NT$96.20-5.2%-7.5%NT$13.8bNT$120.00PE37.3xE-26.3%1.6%

1783

Maxigen Biotech
NT$43.704.4%-10.4%NT$3.9bn/aPE25.1xn/a2.3%

4108

PhytoHealth
NT$16.201.9%-31.4%NT$3.2bn/aPS19.7xn/an/a

4167

Savior Lifetec
NT$20.601.2%6.2%NT$6.5bn/aPE36.4xn/a0.4%

6566

Chuang Yi Biotech
NT$5.200%-65.3%NT$176.5mn/aPS0.7xn/an/a

1789

ScinoPharm Taiwan
NT$23.652.8%-9.4%NT$18.7bn/aPE46.8xn/a1.3%

4743

Oneness Biotech
NT$105.00-1.4%-46.0%NT$50.1bNT$234.00PS446.8xE36.8%0%

6549

TaiwanJ Pharmaceuticals
NT$9.32-1.3%-41.9%NT$746.7mn/aPB13xn/an/a

6712

Ever Supreme Bio Technology
NT$176.000.9%-1.7%NT$14.2bn/aPE55.8xn/a3.1%

6634

Sinew Pharma
NT$50.00-3.8%-28.3%NT$3.6bn/aPB2.8xn/an/a

6785

Alar Pharmaceuticals
NT$151.504.1%-24.4%NT$10.1bNT$290.00PE25.3xS-133.2%1.0%

6949

Pell Bio-Med Technology
NT$89.803.2%n/aNT$5.2bn/aPS281.5xn/an/a

6446

PharmaEssentia
NT$571.00-8.2%58.4%NT$189.7bNT$853.50PE102.8xE92.0%n/a

6875

Pharmosa Biopharm
NT$57.60-8.6%-33.3%NT$7.4bn/aPS147.1xn/an/a

4168

GlycoNex Incorporation
NT$24.900.8%-12.6%NT$2.7bn/aPS233.8xn/a0%
Page 1 of 4
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.